Skip to main content
SpringerLink
Log in

Central Giant Cell Reparative Granuloma (CGCRG) of the Jaw in Children Treated with Neoadjuvant Bisposphonates: Review and a Case Report

  • Clinical Report
  • Published:
Indian Journal of Otolaryngology and Head & Neck Surgery Aims and scope Submit manuscript

Abstract

Central giant cell reparative granuloma (CGCRG) of the jaw is a neoformation localized in the mandible or in the maxillary bone and characterized by fibrous tissue, osteoclast-like giant cells and reactive bone formation. The CGCRG is a less frequent benign tumor but sometimes it is characterized by an aggressive behavior with a very rapid growth. It affects the young adults mainly and the children occasionally. Nowadays no medication therapy is approved for CGCRG in pediatric cases. We present a case of an aggressive form of a mandibular CGCRG in a 5-year child with Arnold-Chiari syndrome. This case is unique for the use of bisphosphonates (BPs) as neoadjuvant therapy in pediatrics. The therapy were administrated with the purpose of arresting the rapid growth of the tumor in order to avoid a demolitive surgery to the young patient. The child was without symptoms and presented an unusual swelling in the left mandible developed in a few weeks. The lesion was diagnosed by a CT scan and it was confirmed by a biopsy performed for histopathological assessment a few days later. The drug therapy consisted of seven cycles iv of Zoledronate associated to Calcium Gluconate. The child was closely observed through clinical and serological evaluations during the following months. About five months after the last cycle of BPs the child underwent CT scan and a conservative surgical treatment, consisted in a deep curettage, was programmed. Seven months after surgery the aesthetic profile of the patient improved and CT scan reported a significant calcic neoapposition in the area of the previous bone lesion. After more than one year from surgery, no relapse was observed. This case report demonstrates that BPs can be used safely in pediatric patients with CGCRG. Especially BPs could have a role as neoadjuvant therapy: If administrated before surgical treatment BPs avoid the necessity of resective surgery and reduce the risk of recurrence in pediatric CGCRG after conservative curettage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Jaffe HL (1953) Giant-cell reparative granuloma, traumatic bone cyst, and fibrous (fibro-oseous) dysplasia of the jawbones. Oral Surg Oral Med Oral Pathol 6(1):159–175

    Article  CAS  PubMed  Google Scholar 

  2. Ramesh V (2020) Central giant cell granuloma—an update. J Oral Maxillofac Pathol 24(3):413–415

    Article  CAS  PubMed  Google Scholar 

  3. Choe M, Smith V, Okcu MF, Wulff J, Gruner S, Huisman TAGM, Venkatramani R (2021) Treatment of central giant cell granuloma in children with denosumab. Pediatr Blood Cancer 68(3):e28778

    Article  CAS  PubMed  Google Scholar 

  4. Harris M (1993) Central giant cell granulomas of the jaws regress with calcitonin therapy. Br J Oral Maxillofac Surg 31(12):89–94

    Article  CAS  PubMed  Google Scholar 

  5. Vered M, Shohat I, Buchner A, Dayan D, Taicher S (2007) Calcitonin nasal spray for treatment of central giant cell granuloma: clinical, radiological, and histological findings and immunohistochemical expression of calcitonin and glucocorticoid receptors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104(2):226–239

    Article  PubMed  Google Scholar 

  6. Goldman KE, Marshall MK, Alessandrini E, Bernstein ML (2005) Complication of alpha-interferon therapy for aggressive central giant cell lesion of the maxilla. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100(3):285–291

    Article  PubMed  Google Scholar 

  7. Pogrel MA, Hossaini-Zadeh M (2021) Denosumab for the treatment of central giant cell granuloma of the jaws—a case series. Int J Oral Maxillofac Surg 50(8):1019–1022

    Article  CAS  PubMed  Google Scholar 

  8. Lipplaa A, Dijkstra S, Gelderblom H (2019) Challenges of denosumab and other giant cell-rich tumors of bone. Curr Opin Oncol 31(4):329–335

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Bredell M, Rordorf T, Kroiss S, Rucker M, Zweifel DF, Rostetter C (2018) Denosumab as a treatment alternative for central giant cell granuloma: a long-term retrospective cohort study. J Oral Maxillofac Surg 76(4):775–784

    Article  PubMed  Google Scholar 

  10. Rytkonen E, Ottavainen V, Rytkonen A, Uusitalo S, Lehenkari P, Sandor JK (2018) Denosumab treatment for aggressive multiple recurrent familial central giant-cell granulomas. Ann Maxillofac Surg 8(2):265–269

    Article  PubMed  PubMed Central  Google Scholar 

  11. Hameed M, O’Connell JE, Rogers SN (2019) Management of an aggressive giant cell granuloma of the mandible with denosumab: a case report. Br J Oralmaxillofac Surg 57(7):691–693

    Article  CAS  Google Scholar 

  12. Mariz B, Migliorati CA, Alves FA, Penteado FM, Carvalho NP, Santos-Silva AR, Rocha AC (2021) Succesfull denosumab treatment for central giant cell granuloma in a 9 year-old child. Spec Care Dentist 41(4):519–525

    Article  PubMed  Google Scholar 

  13. Chien MC, Mascarenhas L, Hammoudeh JA, Venkatramani (2015) Zoledronic acid for the treatment of children with refractory central giant cell granuloma. J Pediatric Hematol Oncol. 37(6):399–401

    Article  Google Scholar 

  14. Nilesh K, Dadhich A, Patil R (2020) Management of recurrent central giant cell granuloma of mandible using intralesional corticosteroid with long-term follow-up. BMJ Case Rep 13(9):e237200

    Article  PubMed  PubMed Central  Google Scholar 

  15. de Arruda JAA, Martins AFL, Abreu LG, Mesquita RA, von Zeidler SV, Estrela C, Mendoça EF (2021) Central giant cell granuloma of the maxilla: long term follow-up of a patient treated with an adjuvant corticosteroid. Spec Care Dentist 41(3):399–407

    Article  PubMed  Google Scholar 

  16. Nogueira RLM, Osterne RLV, Lima Verde RMB, Azevedo NO, Teixeira RC, Cavalcante RB (2020) Intralesional injection of triamcinolone hexacetonide as an alternative treatment for central giant cell lesions: a prospective study. Br J Oral Maxillofacial Surg 58(10):e283–e289

    Article  CAS  Google Scholar 

  17. de Mendonça RP, Mitre GP, Real FH, da Silva Kataoka MS, de Melo Alves Júnior S, Vianna P, da Silva Júnior NG, de Jesus Viana Pinheiro J (2020) Central giant cell granuloma treated with intralesional corticosteroid injections and bisphosphonates: a long-term follow-up case study. Head Neck Pathol 14(2):497–502

    Article  PubMed  Google Scholar 

  18. Lin J, Mecham JC, Hall SR, Oh C, Lettieri S (2020) Pediatric mandibular central giant cell granuloma: neoadjuvant immunotherapy to minimize surgical resection. J Craniofac Surg. https://doi.org/10.1097/SCS.0000000000007112

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biomedical and Dental Sciences and of Morphological and Functional Images, University of Messina, Messina, Italy

    Luciano Catalfamo, Danilo De Rinaldis, Samuele Cicchiello, Calogero Scozzaro, Carla Nava & Francesco Saverio De Ponte

Authors
  1. Luciano Catalfamo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Danilo De Rinaldis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Samuele Cicchiello
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Calogero Scozzaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Carla Nava
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Francesco Saverio De Ponte
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Danilo De Rinaldis.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Catalfamo, L., De Rinaldis, D., Cicchiello, S. et al. Central Giant Cell Reparative Granuloma (CGCRG) of the Jaw in Children Treated with Neoadjuvant Bisposphonates: Review and a Case Report. Indian J Otolaryngol Head Neck Surg 75, 1117–1122 (2023). https://doi.org/10.1007/s12070-022-03413-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12070-022-03413-6

Keywords

Search

Navigation